采用cDNA的末端快速扩增(Rapid amplificationn of cDNA ends)技术,以代表性差异分析cDNA-RDA(Representational difference analysis of cDNA)技术获得的低温诱导甜菜茎尖中差异表达的基因片段为模板,进行巢式PCR扩增,然后根据RACE拼...采用cDNA的末端快速扩增(Rapid amplificationn of cDNA ends)技术,以代表性差异分析cDNA-RDA(Representational difference analysis of cDNA)技术获得的低温诱导甜菜茎尖中差异表达的基因片段为模板,进行巢式PCR扩增,然后根据RACE拼接结果合成引物,分别以低温诱导的cDNA和DNA为模板进行PCR扩增,克隆测序后获得1个全长609 bp的cDNA和855 bp的DNA,分别命名为Ty7Br600和Ty7Br900,在GenBank注册,登录号分别为AY324115和AY324114。在GenBank库中的核苷酸序列比较未发现它们的同源序列,因此认为这个cDNA序列可能是甜菜的一个新基因。展开更多
Objective： To identify aberrant gene expression in primary human T-cell acute lymphoblastic leukemia （T-ALL） and to evaluate the differently expressed level of Lyll and LMO2 genes in human LMO2 positive/TALl negati...Objective： To identify aberrant gene expression in primary human T-cell acute lymphoblastic leukemia （T-ALL） and to evaluate the differently expressed level of Lyll and LMO2 genes in human LMO2 positive/TALl negative T-ALL tumors. Methods： Three methods, representational difference analysis （RDA） of cDNA, cDNA microarrays and RT-PCR were used to detect if Lyll and LMO2 genes were differently expressed in human LMO2 positive/tall negative T-ALL tumors. Results： The results of cDNA RDA and cDNA array shown that Lyll and LMO2 genes are differently expressed in human T-cell tumors. The result of RT-PCR also shown Lyll and LMO2 are high expressed in human T-cell tumors and very low level or no expressed in normal group. Conclusion： We have found that cDNA RDA and cDNA microarray can be successfully used to identify aberrant gene expression in T-ALL cells. In the study described in this manuscript we found that Lyll and LMO2 are aberrantly expressed in human T-ALL LMO2 positive/TALl negative T-ALL tumors.展开更多
文摘Objective： To identify aberrant gene expression in primary human T-cell acute lymphoblastic leukemia （T-ALL） and to evaluate the differently expressed level of Lyll and LMO2 genes in human LMO2 positive/TALl negative T-ALL tumors. Methods： Three methods, representational difference analysis （RDA） of cDNA, cDNA microarrays and RT-PCR were used to detect if Lyll and LMO2 genes were differently expressed in human LMO2 positive/tall negative T-ALL tumors. Results： The results of cDNA RDA and cDNA array shown that Lyll and LMO2 genes are differently expressed in human T-cell tumors. The result of RT-PCR also shown Lyll and LMO2 are high expressed in human T-cell tumors and very low level or no expressed in normal group. Conclusion： We have found that cDNA RDA and cDNA microarray can be successfully used to identify aberrant gene expression in T-ALL cells. In the study described in this manuscript we found that Lyll and LMO2 are aberrantly expressed in human T-ALL LMO2 positive/TALl negative T-ALL tumors.
